Topic: 
Cardiovascular Disease and T2D: Defining the link between T2D and Heart Failure 

Objectives: 

• Describe the link between T2D and HF and review diabetic / non-diabetic cardiomyopathy
• Discuss clinical perspectives on HFpEF and HFrEF.
• Understand approved treatment options for HF in patients with T2D and without diabetes patients
• Describe the effects of SGLT2 inhibition in the prevention and treatment of HF

Speaker: 
Rachelle Richner, MSN, CRNP, NP-C

This webinar is brought to you through a partnership with AstraZeneca.